Shockwave Medical Completes Acquisition of Neovasc

Santa Clara, California–(Newsfile Corp. – April 11, 2023) – Shockwave Medical, Inc. (NASDAQ: SWAV) (“Shockwave”), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified cardiovascular disease, today announced the completion of its previously announced acquisition of Neovasc Inc. (“Neovasc”). The Neovasc Reducer System (the “Reducer”) is…Read More

Leave a Reply

Your email address will not be published. Required fields are marked *